Drugs Affecting Thyroid Gland Flashcards
TH SYNTHESIS AND SECRETION
- Iodide uptake from blood to the follicle cell
- Na+/I− symporter (NIS)
- Iodide moved into the lumen
- Pendrin1 (PDS), an I−/Cl− porter
- Organification of iodide
-.Oxidation of iodide and incorporation into thyroglobulin on tyrosine residues,- Catalysed by thyroperoxidase
- ’ Coupling
Monoiodotyrosine (MIT)
Di-iodotyrosine (DIT)
MIT combines with DIT to form T3
Two DIT molecules combine to form T4
Thyroperoxidase involved - Thyroglobulin molecule taken up into follicle cell by endocytosis
- Endocytotic vesicles fuse with lysosomes
- Proteolytic enzymes act on thyroglobulin
- T 4 and T3 released and secreted into the plasma
TH PHYSIOLOGICAL ACTION
- Metabolic effects
- Growth + development
Metabolic Effects
• Increase and regulation of metabolism: proteins,
fats, carbohydrates
• Oxygen consumption increase and heat
production: increase basal metabolic rate
• Increased cardiac rate and output
Growth & Development
• Directly • Indirectly via GH
production & potentiation • Skeletal development • Development of CNS
TH REGULATION
[TRH+ TSH]
Thyrotrophin-releasing hormone (TRH)
Released from hypothalamus
Releases thyroid-stimulating hormone (TSH) from
anterior pituitary
TSH
Trophic action on thyroid cells
Controls TH synthesis & secretion
Negative feedback control via TH on anterior
pituitary
Somatostatin reduces TSH release
TH REGULATION
Plasma iodide concentration
- Reduced iodine intake
Decrease TH production
Increase TSH secretion
Increase in gland vascularity and hypertrophy - Increased plasma iodide
Size and vascularity of thyroid reduced
‘
THYROID FUNCTION ABNORMALITIES
For Hyperthyroidism (thyrotoxicosis)
Hyperthyroidism (thyrotoxicosis)
- Grave’s disease
- Auto-antibodies against TSH receptor
- Leads to activation - Toxic nodular goiter
- Benign neoplasm or adenoma - Simple, non-toxic goiter
- Iodine dietary deficiency
• Rise in plasma TRH and eventually an increase in
the size of the gland
- Iodine dietary deficiency
DRUGS USED TO TREAT HYPERTHYROIDISM
Radio-iodine Thioureylenes Iodine Adjunct
RADIO-IODINE MoA
Generally considered first-line treatment for
hyperthyroidism
Isotope used is 131I
Emits both β and γ radiation (so it’s cytotoxic to to cells)
-RADIO-IODINE RoA
Given orally
Taken up and processed by thyroid
Incorporated into thyroglobulin
[Β particles exert powerful cytotoxic action
- Restricted to cells of the thyroid follicles
- Significant destruction of tissue ]
Radio-iodine max. effects+ AE
Effects seen after 1-2 months and maximal effects 2 months later
Hypothyroidism develops eventually
Managed by replacement therapy with T 4
RADIO-IODINE CI
Best avoided in children and pregnancy
RADIO-IODINE Clinical use
Used diagnostically for thyroid function
THIOUREYLENES exs.
Carbimazole, methimazole (active metabolite of
carbimazole), propylthiouracil PTU
THIOUREYLENES MoA
Clinical response may take several weeks
Mechanism of action: decrease the output of
thyroid hormones from the gland
- May competitively inhibit the thyroperoxidase- Clinical response may take several weeks catalysed oxidation reactions : • Oxidation of iodine and thyroglobulin • Organification of iodine • Coupling